Yu, Joshua
Dan, Nirnoy
Eslami, Seyyed Majid
Lu, Xiuling
Article History
Received: 2 January 2024
Accepted: 29 February 2024
First Online: 21 March 2024
Declarations
:
: Dr. Xiuling Lu is an inventor of intellectual property licensed to Nami Therapeutics Corp for developing silica nanoparticle-based radiopharmaceuticals. Dr. Xiuling Lu owns equity. It is important to note that the analysis and interpretation in this review were without any influence from the potential financial gains. The authors affirm that the conclusions drawn and the information provided in this paper are based on scientific evidence.